))
Chaperoning innovation through the valley of death
Manage episode 317592203 series 3291201
Contenu fourni par CCRM. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par CCRM ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
The business of regenerative medicine and investment.
Featuring:
Dr. Cynthia Lavoie, President and Chief Investment Officer, CCRM Enterprises
Geoff MacKay, President and CEO, AVROBIO
Dr. Lavoie and Mr. MacKay share what brought them to regenerative medicine in the first place, why investors are bullish about the field, and which trends they have an eye on as they are looking to the future. Join our guests and CCRM’s host, Krista Lamb, as we unpack the business of regenerative medicine to understand what investors look for and how investment can help innovations through the infamous “valley of death,” where new inventions often fail en route to the clinic.
Thanks for listening to Commercializing Living Therapies with CCRM. Spread the word about this episode by taking a screen cap on your device and posting it to social media using the hashtag #CCRMpodcast. Please leave us a review on your favourite streaming service. Find more episodes at ccrm.ca/podcast.
19 episodes
Partager
